Latest Headlines

31. Roche's Elecsys® pTau181 Becomes The Only FDA-Cleared Blood Test For Use In Primary Care To Rule Out Alzheimer's-Related Amyloid Pathology 10/13/2025

    Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the United States Food and Drug Administration (FDA) has cleared its Elecsys pTau181 test, the only blood-based biomarker (BBM) test indicated as an aid in the initial assessment for Alzheimer's disease and other causes of cognitive decline in the primary-care setting.

32. Breakthrough In Blood Test For Alzheimer's By University Of York Researchers 10/9/2025

    Researchers have made a significant breakthrough in the development of a blood test for Alzheimer’s, creating a new sensor design that is ultra-sensitive, outperforms competing technologies and can be built into a handheld device.

33. Cost-Efficient And Proven Solution For Sample Testing 10/9/2025

    Developed to meet the highest standards in sample integrity, Micronic’s Non-Coded and Alphanumeric Coded tubes provide laboratories worldwide with reliable, durable, and contamination-free solutions for accurate testing.

34. Bluejay Diagnostics And SanyoSeiko Expand Strategic Partnership To Advance Commercialization Of Symphony Platform 10/9/2025

    Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”), a medical diagnostics company focused on developing rapid near-patient testing solutions for critical care, today announced that it has entered into an Agreement to Amend the Master Service Agreement and the Master Supply Agreement with SanyoSeiko Co., Ltd. (“SanyoSeiko”), a Japan-based contract manufacturer specializing in medical devices and precision engineering.

35. Kidney Test Being Developed For Early Intervention And Easy Monitoring 10/8/2025

    A simple blood test could reveal kidney disease earlier so more can be done to halt progression, while also allowing better ongoing management of kidney health by simpler monitoring.

36. BD And Opentrons Collaborate To Accelerate Single-Cell Multiomics Discoveries With Robotic Automation 10/8/2025

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Opentrons Labworks, Inc., recognized worldwide for accessible lab automation with more than 10,000 robotic systems deployed, today announced a multi-year collaboration.

37. CND Life Sciences Is Granted FDA Breakthrough Device Designation For Its Skin Biopsy-Based Syn-One Test® 10/7/2025

    CND Life Sciences, Inc. (CND), a medical technology company pioneering the development of cutaneous neurodiagnostic tests and associated biomarker services, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) for the company's Syn-One Test® for aiding the diagnosis of synucleinopathies in patients aged 40 years and older with neurologic conditions that present with clinical features suggestive of a synucleinopathy.

38. PacBio Expands Partnership With seqWell To Bring Scalable Long Read Sample Prep To More Labs 10/7/2025

    PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced an expanded partnership with seqWell, a global provider of genomic library and multiplexing workflow solutions.

39. Countable Labs Launches Revolutionary Ten-Color PCR Platform, Bridging The Gap Between PCR And Next-Generation Sequencing Technologies 10/7/2025

    Countable Labs, the developer of Countable PCR, a category-defining PCR technology that sets a new benchmark for sensitivity in genomics, announced the launch of Countable 10, the first and only PCR platform capable of 10-color multiplexing.

40. Tosoh Announces 510k Clearance For Highly Anticipated Next-Generation GR01 HbA1c Analyzer: A Fast, Accurate And Efficient Solution For A1c Testing 10/6/2025

    Tosoh Bioscience, Inc., a market leader in clinical diagnostics is proud to announce that it has received US FDA 510(k) clearance for its next-generation system for HbA1c testing - the Tosoh Automated Glycohemoglobin Analyzer HLC®723-GR01 (hereafter "GR01").